| News | Treatments
To what extent is Sovaldi effective against hepatitis C?

Miguel Ángel Oliver interviews in Cuatro News the international expert Vicente Carreño. Those affected by hepatitis C claim that the 35,000 most serious cases immediately receive the drug Sovaldi.

| Treatments
Keys to stop the development of hepatitis C medicines apart

Hepatitis C has become the real protagonist of Spanish health for a few months, as a result of the protests initiated by patients (with enclosures in hospitals included).

| Hepatitis-C
Hepatitis C: challenge for Health

We participated in the conversation Hepatitis C: Challenge for health, promoted by Fuinsa and Servimedia and that took place in the Press Association of Madrid.

| Hepatitis-C | Treatments
Efficacy of Immunotherapy with TG4040 in Chronic Hepatitis

TG4040 is a modified Ankara vaccine virus that expresses the hepatitis C virus NS3, NS4 and NS5B proteins (therapeutic vaccine). The Foundation participated in a phase II clinical trial in patients with chronic hepatitis C.

| News
New studies highlighted in the annual congress on the study of liver diseases

Between November 1-5, 2013, the 64th Annual Congress of the American Association for the Study of Liver Disease was held in Washington (USA)

| Treatments
Treatment of chronic hepatitis C with faldaprevir and deleobuvir

En agosto la revista New England Journal of Medicine publica un artículo sobre el tratamiento libre de interferón de la hepatitis crónica C con Faldaprevir (inhibidor de la proteasa del virus) y Deleobuvir (inhibidor de la polimerasa vírica).

| Hepatitis-C | News
New publication on Occult Hepatitis C

A new study by members of the Foundation for the Study of Viral Hepatitis on the presence of hidden hepatitis C in patients with chronic hepatitis B is published in the Journal of Medical Microbiology.

| Hepatitis-C
Latest news about hepatitis C

In January of this year two important studies of Hepatitis C treatment without interferon have been published. So Kowdley et al (NEJMed, 222-232) have used three inhibitory drugs from different areas of the C virus.

Artículos destacados

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

© 2018 - 2025 FEHV Clinic. All rights reserved.  Privacy Policy.  Cookies Policy.  Legal Notice.